Since the main component of pathological inclusions observed in PD and PSP are α-synuclein and tau, respectively, these proteins have gained much attention as biomarkers, particularly in their pathological aggregation-prone forms (oligomeric α-synuclein and phosphorylated tau) [4]. The gene discussed is SNCA; the disease is supranuclear palsy, progressive, 1.